Literature DB >> 32375918

Changes in visual memory in mild cognitive impairment: a longitudinal study with CANTAB.

María Campos-Magdaleno1, David Leiva2, Arturo X Pereiro1, Cristina Lojo-Seoane1, Sabela C Mallo1, David Facal1, Onésimo Juncos-Rabadán1.   

Abstract

BACKGROUND: Mild cognitive impairment (MCI), as a stage in the cognitive continuum between normal ageing and dementia, is mainly characterized by memory impairment. The aims of this study were to examine CANTAB measures of temporal changes of visual memory in MCI and to evaluate the usefulness of the baseline scores for predicting changes in cognitive status.
METHODS: The study included 201 participants aged over 50 years with subjective cognitive complaints. Visual memory was assessed with four CANTAB tests [paired associates learning (PAL), delayed matching to sample (DMS), pattern recognition memory (PRM) and spatial span (SSP)] administered at baseline and on two further occasions, with a follow-up interval of 18-24 months. Participants were divided into three groups according to the change in their cognitive status: participants with subjective cognitive complaints who remained stable, MCI participants who remained stable (MCI-Stable) and MCI participants whose cognitive deterioration continued (MCI-Worsened). Linear mixed models were used to model longitudinal changes, with evaluation time as a fixed variable, and multinomial regression models were used to predict changes in cognitive status.
RESULTS: Isolated significant effects were obtained for age and group with all CANTAB tests used. Interactions between evaluation time and group were identified in the PAL and DMS tests, indicating different temporal patterns depending on the changes in cognitive status. Regression models also indicated that CANTAB scores were good predictors of changes in cognitive status.
CONCLUSIONS: Decline in visual memory measured by PAL and DMS tests can successfully distinguish different types of MCI, and considered together PAL, DMS, PRM and SSP can predict changes in cognitive status.

Entities:  

Keywords:  CANTAB tests; linear mixed models; longitudinal assessment; mild cognitive impairment; visual memory

Mesh:

Year:  2020        PMID: 32375918     DOI: 10.1017/S0033291720001142

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  6 in total

1.  A task-specific cognitive domain decline is correlated with plasma and neuroimaging markers in patients with Parkinson's disease.

Authors:  Cheng-Hsuan Li; Ta-Fu Chen; Pei-Ling Peng; Chin-Hsien Lin
Journal:  J Neurol       Date:  2022-08-14       Impact factor: 6.682

2.  FLAME: A computerized neuropsychological composite for trials in early dementia.

Authors:  Helen Brooker; Gareth Williams; Adam Hampshire; Anne Corbett; Dag Aarsland; Jeffrey Cummings; Jose Luis Molinuevo; Alireza Atri; Zahinoor Ismail; Byron Creese; Tormod Fladby; Charlotte Thim-Hansen; Keith Wesnes; Clive Ballard
Journal:  Alzheimers Dement (Amst)       Date:  2020-10-14

3.  The Relationship Between Hearing Loss and Cognitive Impairment in a Chinese Elderly Population: The Baseline Analysis.

Authors:  Xinxing Fu; Bo Liu; Shuo Wang; Robert H Eikelboom; Dona M P Jayakody
Journal:  Front Neurosci       Date:  2021-11-26       Impact factor: 4.677

4.  Differential associations of visual memory with hippocampal subfields in subjective cognitive decline and amnestic mild cognitive impairment.

Authors:  Yanlu Huang; Lin Huang; Yifan Wang; Yuchen Liu; Chun-Yi Zac Lo; Qihao Guo
Journal:  BMC Geriatr       Date:  2022-02-24       Impact factor: 3.921

5.  The Effects of Lutein and Zeaxanthin Supplementation on Cognitive Function in Adults With Self-Reported Mild Cognitive Complaints: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Adrian L Lopresti; Stephen J Smith; Peter D Drummond
Journal:  Front Nutr       Date:  2022-02-17

6.  The pattern glare and visual memory are disrupted in patients with major depressive disorder.

Authors:  Min Wang; Xiongwei Qi; Xiao Yang; Huanhuan Fan; Yikai Dou; Wanjun Guo; Qiang Wang; Eric Chen; Tao Li; Xiaohong Ma
Journal:  BMC Psychiatry       Date:  2022-08-02       Impact factor: 4.144

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.